[Mediators of inflammation's clinical relevance in multiple myeloma].
Multiple myeloma is a blood disease characterized amongst other things by at least 10% plasmocytes in the bone marrow. The illness is always lethal. The Salmon & Durie classification is well established to evaluate the prognosis. Other parameters are under study in order to supplement it, among them mediators of inflammation such as CRP and LDH. A 5-year study assessing these 2 parameters and their clinical relevance is presented.
Stevens
V
V
Service d'Hémato-Oncologie, CHBA Seraing, Liège, Belgique.
D014408:Biomarkers, Tumor / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000209:etiology; D045022:Lactate Dehydrogenases / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood* / Q000150:complications / Q000276:immunology / Q000401:mortality; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate
D014408:Biomarkers, Tumor; D002097:C-Reactive Protein; D045022:Lactate Dehydrogenases